Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LGMD2E”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Ended earlyNCT03652259
What this trial is testing

Gene Delivery Clinical Trial of SRP-9003 (Bidridistrogene Xeboparvovec) for Participants With Limb-Girdle Muscular Dystrophy, Type 2E (LGMD2E) (Beta-Sarcoglycan Deficiency)

Who this might be right for
Limb-Girdle Muscular Dystrophy, Type 2E
Sarepta Therapeutics, Inc. 6
Not applicableUnknownNCT03492346
What this trial is testing

Limb Girdle Muscular Dystrophy Type 2E Recruitment Study

Who this might be right for
Limb-Girdle Muscular Dystrophy, Type 2E
Nationwide Children's Hospital 25
Early research (Phase 1)Active Not RecruitingNCT05876780
What this trial is testing

A Gene Transfer Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of SRP-9003 in Non-Ambulatory and Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2E/R4 (Beta-Sarcoglycan [β-SG] Deficiency)

Who this might be right for
Limb Girdle Muscular Dystrophy
Sarepta Therapeutics, Inc. 6
Large-scale testing (Phase 3)Active Not RecruitingNCT06246513
What this trial is testing

A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4

Who this might be right for
Limb-girdle Muscular Dystrophy
Sarepta Therapeutics, Inc. 17
Not applicableLooking for participantsNCT05989620
What this trial is testing

Long-Term Development of Muscular Dystrophy Outcome Assessments

Who this might be right for
LGMD1BLGMD1CLGMD1D+26 more
Virginia Commonwealth University 1,000
Not applicableStudy completedNCT04509609
What this trial is testing

Clinical Determinants of Disease Progression in Patients With Limb Girdle Muscular Distrophy Type 2E

Who this might be right for
LGMD2E
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 33
Not applicableStudy completedNCT03488784
What this trial is testing

Natural History of Limb Girdle Muscular Dystrophy Type 2A and Type 2E

Who this might be right for
Limb-Girdle Muscular Dystrophy Type 2ALimb-Girdle Muscular Dystrophy, Type 2E
Lindsay Alfano 100
Not applicableActive Not RecruitingNCT04475926
What this trial is testing

The Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

Who this might be right for
Limb-girdle Muscular Dystrophy
Sarepta Therapeutics, Inc. 205
Not applicableStudy completedNCT02428985
What this trial is testing

Prospective, Non-interventional, Multi-center, Post-authorization Safety Study of Riociguat for Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Hypertension, Pulmonary
Bayer 882